EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (2 hours ago)
RT @LabsExplorer: Tomorrow's webinar >> In Vitro Biology and Toxicology: Emerging Methods and Best Practices - by @edelweissconn https://t…
Edelweiss Connect (2 hours ago)
Join us for this week's #SaferWorldbyDesign panel webinar and discussion: In Vitro Biology and Toxicology - Emergin… https://t.co/00f76FXSo9
Edelweiss Connect (3 days ago)
RT @barryhardy: Consider meeting with us at the @EU_ToxRisk booth at #2021SOT #ToxExpo to discuss risk assessment supported by integrated t…
Edelweiss Connect (6 days ago)
In Vitro Biology and Toxicology: Emerging Methods and Best Practices March 9, 2021, 16-18 CET A… https://t.co/Q4N1O6EtFo
Edelweiss Connect (2 weeks ago)
RT @barryhardy: #SaferWorldbyDesign data management and analysis example using web-based notebook technology and #EdelweissData applied to…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA